Trial intelligence / Profile preview

Propofol during IVF anesthesia in women with migraine

IRCT20190131042569N3Phase 2Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of propofol in migraine, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Effect of propofol on severity of migraine headache attacks and Effect of propofol on frequency of migraine headache attacks. Started May 2019; status: completed.

02

Drugs

propofol
03

Conditions

migraine

Beyond the preview

Go deeper on IRCT20190131042569N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190131042569N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call